Vimarsana
Biggest News Aggregation in the World

Impact Moderna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impact Moderna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impact Moderna Today - Breaking & Trending Today

Why Moderna Stock Is Down 25% Over The Last Month -- Trefis - Vimarsana News

Why Moderna Stock Is Down 25% Over The Last Month -- Trefis

  Covid-19 Vaccine stocks – which includes U.S.-listed pharma and biotech companies. The theme is up by about 640% year-to-date versus about 13% for the S&P 500. [Updated 11/11/2020] Why Pfizer’s Vaccine Data Is Good News For Moderna While Pfizer‘s (NYSE: PFE) surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn’t mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong data from the vaccine – which is developed...

Source: trefis.com
Pfizer Vaccine Updates: Possibly Easier Storage, Efficacy Against South African Strain -- Trefis - Vimarsana News

Pfizer Vaccine Updates: Possibly Easier Storage, Efficacy Against South African Strain -- Trefis

Last week, there were two positive developments relating to Pfizer (NYSE: PFE) and its German partner BioNTech’s Covid-19 vaccine, and one possible negative development. Firstly, Pfizer says based on internal testing that its vaccine can tolerate warmer temperatures than initially specified, possibly making it easier to handle and distribute. Under current protocol, the vaccine is being stored and transported at ultra-cold temperatures of -80 to -60 degrees Celsius until five days before use, calling for specialized equipment and a longer thawing period. However, the company is now asking ...

Source: trefis.com
Why Moderna Stock Is Already Up 25% This Year -- Trefis - Vimarsana News

Why Moderna Stock Is Already Up 25% This Year -- Trefis

  Covid-19 Vaccine stocks – which includes U.S.-listed pharma and biotech companies. The theme is up by about 640% year-to-date versus about 13% for the S&P 500. [Updated 11/11/2020] Why Pfizer’s Vaccine Data Is Good News For Moderna While Pfizer‘s (NYSE: PFE) surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn’t mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong data from the vaccine – which is developed...

Source: trefis.com
Can Moderna Rise To The Manufacturing Challenge? -- Trefis - Vimarsana News

Can Moderna Rise To The Manufacturing Challenge? -- Trefis

As we've said before, Moderna's Covid-19 vaccine is likely to emerge as the most sought after vaccine in developed markets, considering its stellar efficacy rates and relative ease of storage.

Source: trefis.com